GO:0071013 | catalytic step 2 spliceosome | 5.67e-04 | 1.00e+00 | 5.738 | 2 | 5 | 61 |
GO:0004151 | dihydroorotase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 8.11e-04 | 1.00e+00 | 5.479 | 2 | 7 | 73 |
GO:0005654 | nucleoplasm | 8.33e-04 | 1.00e+00 | 2.894 | 4 | 55 | 876 |
GO:0005829 | cytosol | 1.04e-03 | 1.00e+00 | 2.187 | 5 | 58 | 1787 |
GO:0000056 | ribosomal small subunit export from nucleus | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0003924 | GTPase activity | 2.14e-03 | 1.00e+00 | 4.774 | 2 | 3 | 119 |
GO:0051414 | response to cortisol | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0000398 | mRNA splicing, via spliceosome | 2.47e-03 | 1.00e+00 | 4.668 | 2 | 8 | 128 |
GO:0006184 | GTP catabolic process | 2.55e-03 | 1.00e+00 | 4.646 | 2 | 3 | 130 |
GO:0016020 | membrane | 2.83e-03 | 1.00e+00 | 2.431 | 4 | 38 | 1207 |
GO:0010467 | gene expression | 2.89e-03 | 1.00e+00 | 3.190 | 3 | 31 | 535 |
GO:0014075 | response to amine | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0008380 | RNA splicing | 4.07e-03 | 1.00e+00 | 4.302 | 2 | 7 | 165 |
GO:0007067 | mitotic nuclear division | 4.07e-03 | 1.00e+00 | 4.302 | 2 | 8 | 165 |
GO:0075733 | intracellular transport of virus | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0000812 | Swr1 complex | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0000166 | nucleotide binding | 4.62e-03 | 1.00e+00 | 4.209 | 2 | 6 | 176 |
GO:0031122 | cytoplasmic microtubule organization | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0031011 | Ino80 complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0008266 | poly(U) RNA binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0005525 | GTP binding | 5.76e-03 | 1.00e+00 | 4.046 | 2 | 5 | 197 |
GO:0006541 | glutamine metabolic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0043968 | histone H2A acetylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0043234 | protein complex | 6.52e-03 | 1.00e+00 | 3.954 | 2 | 8 | 210 |
GO:0007020 | microtubule nucleation | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 3 | 12 |
GO:0006259 | DNA metabolic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 14 |
GO:0003723 | RNA binding | 8.94e-03 | 1.00e+00 | 3.720 | 2 | 11 | 247 |
GO:0070062 | extracellular vesicular exosome | 8.95e-03 | 1.00e+00 | 1.988 | 4 | 43 | 1641 |
GO:0044822 | poly(A) RNA binding | 9.04e-03 | 1.00e+00 | 2.611 | 3 | 25 | 799 |
GO:0035145 | exon-exon junction complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0007052 | mitotic spindle organization | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0006611 | protein export from nucleus | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 18 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0017144 | drug metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 22 |
GO:0007286 | spermatid development | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 23 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0005634 | nucleus | 1.76e-02 | 1.00e+00 | 1.326 | 5 | 67 | 3246 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 29 |
GO:0042802 | identical protein binding | 1.78e-02 | 1.00e+00 | 3.201 | 2 | 7 | 354 |
GO:0050681 | androgen receptor binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 30 |
GO:0043195 | terminal bouton | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0007595 | lactation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 32 |
GO:0019003 | GDP binding | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0032092 | positive regulation of protein binding | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 35 |
GO:0031124 | mRNA 3'-end processing | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 5 | 38 |
GO:0006417 | regulation of translation | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 39 |
GO:0042995 | cell projection | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 2 | 41 |
GO:0031100 | organ regeneration | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 44 |
GO:0006406 | mRNA export from nucleus | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 44 |
GO:0005730 | nucleolus | 2.89e-02 | 1.00e+00 | 2.004 | 3 | 41 | 1217 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 4 | 51 |
GO:0005643 | nuclear pore | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 2 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 5 | 51 |
GO:0005681 | spliceosomal complex | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0003729 | mRNA binding | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 57 |
GO:0000785 | chromatin | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 5 | 59 |
GO:0007565 | female pregnancy | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 2 | 64 |
GO:0042470 | melanosome | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 2 | 64 |
GO:0005200 | structural constituent of cytoskeleton | 4.11e-02 | 1.00e+00 | 4.581 | 1 | 2 | 68 |
GO:0006325 | chromatin organization | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0001889 | liver development | 4.29e-02 | 1.00e+00 | 4.519 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 1 | 77 |
GO:0019058 | viral life cycle | 4.70e-02 | 1.00e+00 | 4.383 | 1 | 3 | 78 |
GO:0005737 | cytoplasm | 4.89e-02 | 1.00e+00 | 1.306 | 4 | 50 | 2633 |
GO:0030529 | ribonucleoprotein complex | 4.94e-02 | 1.00e+00 | 4.311 | 1 | 4 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 3 | 84 |
GO:0005515 | protein binding | 5.22e-02 | 1.00e+00 | 0.981 | 5 | 76 | 4124 |
GO:0000086 | G2/M transition of mitotic cell cycle | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 5 | 97 |
GO:0016887 | ATPase activity | 5.99e-02 | 1.00e+00 | 4.025 | 1 | 6 | 100 |
GO:0007507 | heart development | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 3 | 109 |
GO:0016607 | nuclear speck | 7.27e-02 | 1.00e+00 | 3.738 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 2 | 125 |
GO:0019904 | protein domain specific binding | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 2 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.42e-02 | 1.00e+00 | 3.519 | 1 | 2 | 142 |
GO:0044281 | small molecule metabolic process | 8.86e-02 | 1.00e+00 | 1.947 | 2 | 32 | 844 |
GO:0005524 | ATP binding | 9.76e-02 | 1.00e+00 | 1.868 | 2 | 23 | 892 |
GO:0007283 | spermatogenesis | 9.89e-02 | 1.00e+00 | 3.276 | 1 | 2 | 168 |
GO:0016071 | mRNA metabolic process | 1.00e-01 | 1.00e+00 | 3.259 | 1 | 21 | 170 |
GO:0043025 | neuronal cell body | 1.01e-01 | 1.00e+00 | 3.251 | 1 | 3 | 171 |
GO:0007264 | small GTPase mediated signal transduction | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 1 | 174 |
GO:0003713 | transcription coactivator activity | 1.08e-01 | 1.00e+00 | 3.145 | 1 | 5 | 184 |
GO:0016070 | RNA metabolic process | 1.10e-01 | 1.00e+00 | 3.114 | 1 | 21 | 188 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 1 | 203 |
GO:0006281 | DNA repair | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 19 | 203 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 4 | 210 |
GO:0005813 | centrosome | 1.26e-01 | 1.00e+00 | 2.907 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 1.27e-01 | 1.00e+00 | 2.900 | 1 | 7 | 218 |
GO:0003682 | chromatin binding | 1.45e-01 | 1.00e+00 | 2.691 | 1 | 6 | 252 |
GO:0000278 | mitotic cell cycle | 1.78e-01 | 1.00e+00 | 2.374 | 1 | 35 | 314 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.92e-01 | 1.00e+00 | 2.255 | 1 | 6 | 341 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.110 | 1 | 10 | 377 |
GO:0005794 | Golgi apparatus | 2.29e-01 | 1.00e+00 | 1.971 | 1 | 5 | 415 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 32 | 428 |
GO:0007165 | signal transduction | 3.25e-01 | 1.00e+00 | 1.397 | 1 | 5 | 618 |
GO:0008270 | zinc ion binding | 3.71e-01 | 1.00e+00 | 1.163 | 1 | 7 | 727 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.597 | 1 | 9 | 1076 |